Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8561 |
High Similarity |
NPD3027 |
Phase 3 |
0.8387 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8271 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8231 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8168 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8134 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8106 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8106 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7917 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD37 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.782 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7676 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7574 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7571 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7519 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1934 |
Approved |
0.75 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7379 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7368 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7324 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7296 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7293 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7266 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7261 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD228 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7179 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7179 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7178 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4675 |
Approved |
0.716 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7105 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD5353 |
Approved |
0.708 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7071 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD919 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5735 |
Approved |
0.705 |
Intermediate Similarity |
NPD1091 |
Approved |
0.705 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5090 |
Approved |
0.6994 |
Remote Similarity |
NPD5242 |
Approved |
0.6993 |
Remote Similarity |
NPD5297 |
Approved |
0.6993 |
Remote Similarity |
NPD1511 |
Approved |
0.6988 |
Remote Similarity |
NPD7472 |
Approved |
0.6981 |
Remote Similarity |
NPD2563 |
Approved |
0.6981 |
Remote Similarity |
NPD2560 |
Approved |
0.698 |
Remote Similarity |
NPD2438 |
Suspended |
0.698 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6974 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD2677 |
Approved |
0.6974 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.697 |
Remote Similarity |
NPD5451 |
Approved |
0.697 |
Remote Similarity |
NPD8252 |
Approved |
0.697 |
Remote Similarity |
NPD8251 |
Approved |
0.697 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6968 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6966 |
Remote Similarity |
NPD5718 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD4536 |
Approved |
0.6959 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4538 |
Approved |
0.6957 |
Remote Similarity |
NPD5585 |
Approved |
0.6954 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD3060 |
Approved |
0.6948 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6947 |
Remote Similarity |
NPD290 |
Approved |
0.6943 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD5535 |
Approved |
0.6939 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6937 |
Remote Similarity |
NPD6788 |
Approved |
0.6933 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6933 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6928 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD7819 |
Suspended |
0.6918 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4585 |
Approved |
0.6918 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD3748 |
Approved |
0.6912 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6908 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD17 |
Approved |
0.6903 |
Remote Similarity |
NPD1512 |
Approved |
0.6903 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD7526 |
Approved |
0.6903 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD52 |
Approved |
0.6899 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7095 |
Approved |
0.6887 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD1372 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD1182 |
Approved |
0.6883 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD6799 |
Approved |
0.6883 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1840 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD2237 |
Approved |
0.6875 |
Remote Similarity |
NPD5402 |
Approved |
0.6875 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6871 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.687 |
Remote Similarity |
NPD968 |
Approved |
0.6867 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6864 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6864
|
Remote Similarity |
NPD7808 |
Phase 3 |